Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis By Sheena Cruz / 03/09/2026
Ublituximab Efficacy Outcomes in Relapsing Multiple Sclerosis Patient Subgroups in the ULTIMATE I and II Studies By admin / 06/26/2022